Notably, pharmacological intervention with FGF4 can suppress adipose macrophage infiltration and inflammation, suggesting its therapeutic potential against AIH, an inflammatory condition characterized by macrophage activation [15]. Here, FGF4 is linked to autoimmune hepatitis.